Effect of inhaled steroid and montelukast on clinical symptoms in children with newly diagnosed asthma: A pilot study

Pediatric Allergy and Immunology

Volumn 21, Issue 4 PART2, 2010, Pages

  Olszowiec Chlebna, Malgorzata ^a   Majak, Pawel ^a   Brzozowska, Agnieszka ^a   Bobrowska Korzeniowska, Monika ^a   Jerzynska, Joanna ^a   Stelmach, Iwona ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Initial therapy; Pediatric asthma

Indexed keywords

ACETIC ACID DERIVATIVE; BUDESONIDE; HOUSE DUST ALLERGEN; MONTELUKAST; QUINOLINE DERIVATIVE;

ADOLESCENT; ANIMAL; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; PATHOPHYSIOLOGY; PILOT STUDY; PRESCHOOL CHILD; PYROGLYPHIDAE; RANDOMIZED CONTROLLED TRIAL;

ACETATES; ADMINISTRATION, INHALATION; ADOLESCENT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BUDESONIDE; CHILD; CHILD, PRESCHOOL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PILOT PROJECTS; PYROGLYPHIDAE; QUINOLINES; RESPIRATORY FUNCTION TESTS;

EID: 79952463611     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2009.00983.x     Document Type: Article

References (14)

1. Bacharier LB, Boner A, Carlsen KH, et al.; European Pediatric Asthma Group. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy. 2008; 63: 5-34. Review. Erratum in: Allergy 2008; 63: 5-34.
2. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2006. Available from: http://www.ginasthma.org.
3. Soyer OU, Beyhun NE, Demir E, et al. A multicenter survey of childhood asthma in Turkey. II: utilization of asthma drugs, control levels and their determinants. Pediatr Allergy Immunol 2009: 20: 172-9.
4. Bateman ED, Bousquet J, Busse WW, et al.; GOAL Steering Committee and Investigators. Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. Allergy 2008: 63: 932-8.
5. Von Berg A, Engelstätter R, Minic P, et al. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma. Pediatr Allergy Immunol 2007: 18: 391-400.
6. Stelmach I, Grzelewski T, Majak P, Jerzynska J, Stelmach W, Kuna P. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol 2008: 121: 383-9.
7. Stelmach I, Grzelewski T, Bobrowska-Korzeniowska M, Stelmach P, Kuna P. A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma. Pulm Pharmacol Ther 2007: 20: 691-700.
8. Warner JO. Do we need more management guidelines? Pediatr Allergy Immunol 2007: 18: 549-50.
9. Skinner EA, Diette GB, Algatt-Bergstrom PJ, et al. The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag 2004: 7: 305-13.
10. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J. Standardisation of lung function tests: 1993 update. Report Working Party for the European Community for Steel and Coal. Eur Respir J 1993: 6: 5-40.
11. Quanjer PhH, Helms P, Bjure J, Gaultier CI. Standardisation of lung function tests in pediatrics. Eur Respir J 1989: 2: 121-264.
12. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005: 26: 319-38.
13. Van Der Heide S, De Monchy JG, De Vries K, Bruggink TM, Kauffman HF. Seasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthma. J Allergy Clin Immunol 1994: 93: 470-5.
14. Riccioni G, Di Stefano F, De Benedictis M, et al. Seasonal variability of non-specific bronchial responsiveness in asthmatic patients with allergy to house dust mites. Allergy Asthma Proc 2001: 22: 5-9.